[{"Assets_0_Q2_USD":1844832000.0,"CommonStockSharesOutstanding_0_Q2_shares":37734646.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":86011000.0,"NetIncomeLoss_1_Q2_USD":17556000.0,"NetIncomeLoss_2_Q2_USD":34958000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":37766000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":37732000.0,"StockholdersEquity_0_Q2_USD":1096425000.0,"EarningsPerShareBasic_1_Q2_USD":0.46,"EarningsPerShareBasic_2_Q2_USD":0.93,"Ticker":"TECH","CIK":"842023","name":"BIO-TECHNE CORP","OfficialName":"Bio-Techne Corp Common Stock","form":"10-Q","period":"20181231","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"16235870966.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"SP500","filed":"20190207"}]